Publications by authors named "F Pinquie"

Claim this Profile
D
Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial.
Valérie Gounant, Laurent Greillier, Céline Mascaux, François Pinquie, Delphine Carmier

JTO Clin Res Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diaphragmatic rupture and right ipsilateral intercostal hernia in chronic cough].
E Cloche, G Dessertenne, J-C Callahan, F Pinquie, J Barbieux

Rev Mal Respir· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non-Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 Mutation.
François Pinquie, Alexis B Cortot, Louise-Marie Chevalier, Alain Morel, Jérémy Sandrini

Clin Lung Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Mutations: Results From the IFCT-1703 R2D2 Trial.
Julien Mazieres, Claire Lafitte, Charles Ricordel, Laurent Greillier, Elodie Negre, François Pinquie

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Unexpected adverse events of immunotherapies in non-small cell lung cancer: About 2 cases].
G de Chabot, G Justeau, F Pinquié, A Nadaj-Pakleza, E Hoppé

Rev Pneumol Clin· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis